Tepmetko
FDA Grants Full Approval to Merck KGaA's Tepmetko in Advanced METex14-Altered NSCLC
The drug garnered accelerated approval from the FDA in 2021, but the agency has now granted full approval based on additional data.
The drug garnered accelerated approval from the FDA in 2021, but the agency has now granted full approval based on additional data.